MedTrace Logo

Impact of Preterm Single Donor Milk in Very Low Birth Weight Infants

NCT02216292 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2014-08-13

No results posted yet for this study

Summary

Human milk is the best source of enteral nutrition for the preterm infant. However during the infants first hours and days of life breastmilk from the own mother is usually not available. Until May 2012 the practice in the Neonatal Division of the Department of Pediatrics /Medical University Vienna was to start with formula feedings within the first 6 hours of life of a premature infant and switch over to breastmilk as soon it was available. In June 2012 the investigators changed this feeding regimen and started to use single donor milk of mothers of preterm infants for the first hours and days of the preterm infants life. In a prospective observational study the investigators evaluated the impact of single donor milk from preterm infants on time to full enteral feedings, gastrointestinal tolerance and NEC incidence in preterm infants with a birthweight below 1500 grams and a gestational below 32 weeks. Data will be compared with a historical control group starting with preterm formula as source of enteral nutrition. The investigators hypothesize that starting enteral nutrition with single donor milk of mothers from preterm infants with shorten time to full enteral feedings.

Conditions

  • Infant, Premature, Diseases

Interventions

OTHER

Control Group

Infants received preterm formula during their first days of life until breastmilk from their own mother was available

OTHER

Preterm Single Donor Milk Group

Infants received preterm single donor milk during their first days of life until breastmilk from their own mother was available

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Nadja Haiden, Prof.MD · Medical University of Vienna, Department of Pediatrics

Eligibility

Min Age
1 Minute
Max Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2013-04-30
Completion
2014-06-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02216292 on ClinicalTrials.gov